| Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine H Luo, CT Vong, H Chen, Y Gao, P Lyu, L Qiu, M Zhao, Q Liu, Z Cheng, ... Chinese Medicine 14 (1), 48, 2019 | 370 | 2019 |
| Astragali Radix (Huangqi): a promising edible immunomodulatory herbal medicine Z Chen, L Liu, C Gao, W Chen, CT Vong, P Yao, Y Yang, X Li, X Tang, ... Journal of ethnopharmacology 258, 112895, 2020 | 201 | 2020 |
| Improved insulin sensitivity despite increased visceral adiposity in mice deficient for the immune cell transcription factor T-bet E Stolarczyk, CT Vong, E Perucha, I Jackson, MA Cawthorne, ET Wargent, ... Cell metabolism 17 (4), 520-533, 2013 | 101 | 2013 |
| Superoxide generation and leukocyte accumulation: key elements in the mediation of leukotriene B4-induced itch by transient receptor potential ankyrin 1 and … ES Fernandes, CT Vong, S Quek, J Cheong, S Awal, C Gentry, ... The FASEB Journal 27 (4), 1664-1673, 2013 | 86 | 2013 |
| Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: opportunities and emerging strategies P Liu, C Gao, H Chen, CT Vong, X Wu, X Tang, S Wang, Y Wang Acta Pharmaceutica Sinica B 11 (9), 2798-2818, 2021 | 75 | 2021 |
| TRPM2 regulates TXNIP-mediated NLRP3 inflammasome activation via interaction with p47 phox under high glucose in human monocytic cells HHL Tseng, CT Vong, YW Kwan, SMY Lee, MPM Hoi Scientific reports 6, 35016, 2016 | 72 | 2016 |
| Turmeric-derived nanovesicles as novel nanobiologics for targeted therapy of ulcerative colitis C Gao, Y Zhou, Z Chen, H Li, Y Xiao, W Hao, Y Zhu, CT Vong, MA Farag, ... Theranostics 12 (12), 5596, 2022 | 62 | 2022 |
| HIF-1: Structure, biology and natural modulators Y Chao, ZF Zhong, W Sheng-Peng, V Chi-Teng, YU Bin, W Yi-Tao Chinese Journal of Natural Medicines 19 (7), 521-527, 2021 | 62 | 2021 |
| Bilirubin Nanomedicines for the Treatment of Reactive Oxygen Species (ROS)-Mediated Diseases Z Chen, CT Vong, C Gao, S Chen, X Wu, S Wang, Y Wang Molecular Pharmaceutics 17 (7), 2260-2274, 2020 | 60 | 2020 |
| Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets Z Zhong, CT Vong, F Chen, H Tan, C Zhang, N Wang, L Cui, Y Wang, ... Medicinal Research Reviews 42 (3), 1246-1279, 2022 | 55 | 2022 |
| Emerging pharmacotherapy for inflammatory bowel diseases H Luo, G Cao, C Luo, D Tan, CT Vong, Y Xu, S Wang, H Lu, Y Wang, ... Pharmacological Research 178, 106146, 2022 | 51 | 2022 |
| Combined effects of berberine and evodiamine on colorectal cancer cells and cardiomyocytes in vitro X Guan, X Zheng, CT Vong, J Zhao, J Xiao, Y Wang, Z Zhong European journal of pharmacology 875, 173031, 2020 | 42 | 2020 |
| Dietary polyphenols for managing cancers: What have we ignored? X Wu, M Li, Z Xiao, M Daglia, S Dragan, D Delmas, CT Vong, Y Wang, ... Trends in Food Science & Technology 101, 150-164, 2020 | 39 | 2020 |
| Rhein regulates redox‐mediated activation of NLRP3 inflammasomes in intestinal inflammation through macrophage‐activated crosstalk Y Zhou, C Gao, CT Vong, H Tao, H Li, S Wang, Y Wang British Journal of Pharmacology 179 (9), 1978-1997, 2022 | 37 | 2022 |
| A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease L Yang, H Luo, D Tan, S Zhang, Z Zhong, S Wang, CT Vong, Y Wang Phytomedicine 92, 153709, 2021 | 37 | 2021 |
| Recent advances in structure-based drug design and virtual screening of VEGFR tyrosine kinase inhibitors PM Hoi, S Li, CT Vong, HHL Tseng, YW Kwan, SMY Lee Methods 71, 85-91, 2015 | 33 | 2015 |
| Novel protective effect of O-1602 and abnormal cannabidiol, GPR55 agonists, on ER stress-induced apoptosis in pancreatic β-cells CT Vong, HHL Tseng, YW Kwan, SMY Lee, MPM Hoi Biomedicine & Pharmacotherapy 111, 1176-1186, 2019 | 32 | 2019 |
| The important herbal pair for the treatment of COVID-19 and its possible mechanisms S Xia, Z Zhong, B Gao, CT Vong, X Lin, J Cai, H Gao, G Chan, C Li Chinese medicine 16, 1-16, 2021 | 31 | 2021 |
| Ginseng: A bibliometric analysis of 40-year journey of global clinical trials W Chen, P Yao, CT Vong, X Li, Z Chen, J Xiao, S Wang, Y Wang Journal of Advanced Research 34, 187-197, 2021 | 29 | 2021 |
| Lysosomal Ca2+ signaling regulates high glucose-mediated interleukin-1β secretion via transcription factor EB in human monocytic cells HHL Tseng, CT Vong, YW Kwan, SMY Lee, MPM Hoi Frontiers in immunology 8, 274481, 2017 | 29 | 2017 |
